Study Links Spinal Muscular Atrophy to Increased Risk of Fatty Liver Disease

Recent international study reveals a concerning link between Spinal Muscular Atrophy (SMA) and an increased risk of fatty liver disease. SMA patients may face liver dysfunction due to reduced SMN protein levels, leading to fat accumulation and inflammation. Editing faulty genes to boost SMN production could reverse liver issues in SMA patients, highlighting the importance of monitoring and addressing liver health in this population.